Related Experiment Video
Updated: May 31, 2026
07:39
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
HIV infection and thromboembolism.
H Basavanagowdappa1, M Suresh Babu, Subrahmanyam Karuturi
1JSS Medical College, Mysore.
The Journal of the Association of Physicians of India
|July 15, 2011
Summary
HIV patients have a higher risk of blood clots. This case highlights a patient with venous thromboembolism, normal CD4 count, and specific clotting factor deficiencies, suggesting a complex hypercoagulable state.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Background:
- Venous thromboembolism (VTE) is a known complication in Human Immunodeficiency Virus (HIV) infection.
- HIV-associated thrombotic disease is often linked to various hemostatic abnormalities.
- A hypercoagulable state can increase the risk of blood clots in affected individuals.
Observation:
- This report details a case of a patient diagnosed with HIV and VTE.
- The patient presented with a normal CD4+ T-cell count at the time of diagnosis.
- Key laboratory findings included decreased levels of Protein C and Protein S, alongside elevated serum homocysteine.
Findings:
- The observed coagulation profile suggests a specific prothrombotic state in this HIV patient.
- Reduced Protein C and Protein S are critical inhibitors of coagulation, their deficiency predisposes to thrombosis.
- Increased homocysteine is an independent risk factor for VTE and may be exacerbated in HIV.
Implications:
- This case underscores that VTE in HIV patients can occur even with preserved immune function (normal CD4 count).
- It highlights the importance of investigating specific coagulation factor deficiencies and homocysteine levels in HIV-associated VTE.
- Understanding these complex hemostatic derangements is crucial for effective VTE prevention and management in the HIV population.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.